Insights provides context and perspective about key pharmacy trends and issues

Cost Management
As part of the CVS Health hyperinflation strategy, our Outlier Pharmacy Program proactively monitors and identifies pharmacies with increased volume in claims submissions of certain drugs. More
Briefing
Innovation
Digital engagement and targeted clinical support through digital channels at the right time have been proven to help patients stay on therapy and can be especially impactful for those with... More
Briefing
Innovation
Consumers want affordable and transparent costs. CVS Health offers solutions that provide visibility and lower member health care costs More
Briefing
Businesswoman wearing a mask, standing in a creative workspace
Innovation
Sree Chaguturu, M.D, chief medical officer, CVS Caremark discusses how Return Ready can support employers in their evolving role in the overall health and wellbeing of their employees,... More
Video
Care Management
In this clinical update, CVS Health leaders share perspective on the recent recalls of certain extended-release metformin formulations, the types and levels of recalls, the role of FDA and... More
Commentary
Innovation
New feature CVS Pharmacy app for patients with visual impairments and those who cannot read standard print labels, helps remove potential barriers to adherence, and makes it easier for... More
Briefing
Innovation
At a time when consumers cannot follow their normal health routines digital solutions offered through Point Solutions Management can supplement traditional care and help close gaps in care. More
Commentary
Care Management
Safe, comprehensive vaccination programs from CVS Caremark provide plan members convenient access to low- or no-cost vaccinations at their local pharmacy. More
Briefing
Read the article: Specialty Pharmacy Pipeline Drugs to Watch - Q3-Q4 2020
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2020 More
Specialty Report
Drug Pipeline
Over the past dozen years, several new treatments have come to market with the first oral preventive expected to be approved in December. Targeted management to help balance access and cost... More
Feature